Welcome : Guest

Summit Therapeutics Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Summit Therapeutics Plc, which is principally involved in Biopharmaceuticals Business. Illustrated with 17 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-45149
Price: $850
Company Type: Public
Pages: 21
Date: November 2016
Market Data Tables: 17

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antibiotics......5
Table 1: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......5
Table 2: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......6
Table 3: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......7
Table 4: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......8
Duchenne Muscular Dystrophy (DMD) Disease......9
Table 5: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in the U.S (2015) - Percentage Breakdown by No. of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......9
Table 6: Duchenne Muscular Dystrophy (DMD) Disease Market by Therapy in European Union (2015) - Percentage Breakdown by No.of Patients for Exon 44, Exon 45, Exon 46, Exon 51, Exon 53, and Others......10
Clostridium Difficile Tests......11
Table 7: Clostridium Difficile Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......11
Molecular Clostridium difficile Equipment......12
Table 8: Molecular Clostridium Difficile Diagnostic Equipment Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Artus Clostridium Difficile, Clostridium Difficile, Clostridium Difficile Assay, Clostridium Difficile Test, Imdx Clostridium Difficile, Progastro Clostridium Difficile, Simplexa Clostridium Difficile, Toxigenic Clostridium Difficile, and Xpert Clostridium Difficile......12
Table 9: Molecular Clostridium Difficile Diagnostic Equipment Market by Instrument Worldwide (2015) - Percentage Share Breakdown by Value Sales for 3M Integrated Cycler, Amplivue, BD MAX, GeneXpert, ICEPlex, Illumigene, m2000, Portrait Analyzer, QIAsymphony, SmartCycler, and Verigene......13
Table 10: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......14
Diagnostics Tests......15
Table 11: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......15
Table 12: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......16
Antibiotics......17
Table 13: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......17
Table 14: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......18
Clostridium Difficile-Associated Diarrhea (CDAD)......19
Table 15: Market Shares of Leading Drugs for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in the US (2015) - Percentage Share Breakdown by Value for METRONIDAZOLE INJECTION, METRONIDAZOLE Oral, VANCOMYCIN Oral Solution and Others......19
Molecular Clostridium difficile Equipment......20
Table 16: Market Shares of Leading Molecular Clostridium Difficile Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Great Basin, Hologic Corporation, Meridian Medical Technologies, Inc., Nanosphere, Inc., Qiagen N.V., Quest Diagnostics, Inc., and Others......20
Molecular Clostridium Difficile (C. Diff) Testing......21
Table 17: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......21